OBIO
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Orchestra BioMed exceeds its full enrollment target in the global pivotal BACKBEAT trial of AVIM therapyOct 1, 2026
- Orchestra BioMed presents new AVIM therapy clinical data at HRX demonstrating substantial and sustained blood pressure reductions reproducible upon reactivation following washoutSep 5, 2025
- Orchestra BioMed publishes clinical data on AVIM therapy in JACC: Advances, showing potential to improve cardiac function in hypertension and diastolic dysfunction patientsAug 14, 2025
- Orchestra BioMed announces rollout of FDA-approved BACKBEAT global pivotal study protocol update significantly expanding patient eligibilityAug 8, 2025
- Orchestra BioMed showcases AVIM therapy as a specialized solution for hypertensive heart disease at CSI Frankfurt 2025Jun 20, 2025